These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 9221969

  • 1. Apolipoprotein E epsilon4 allele decreases functional connectivity in Alzheimer's disease as measured by EEG coherence.
    Jelic V, Julin P, Shigeta M, Nordberg A, Lannfelt L, Winblad B, Wahlund LO.
    J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):59-65. PubMed ID: 9221969
    [Abstract] [Full Text] [Related]

  • 2. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN.
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [Abstract] [Full Text] [Related]

  • 3. Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E epsilon4 allele.
    Juottonen K, Lehtovirta M, Helisalmi S, Riekkinen PJ, Soininen H.
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):322-7. PubMed ID: 9728943
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Single photon emission computed tomography and apolipoprotein E in Alzheimer's disease: impact of the epsilon4 allele on regional cerebral blood flow.
    Høgh P, Knudsen GM, Kjaer KH, Jørgensen OS, Paulson OB, Waldemar G.
    J Geriatr Psychiatry Neurol; 2001 Sep; 14(1):42-51. PubMed ID: 11281316
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A longitudinal quantitative EEG study of Alzheimer's disease: relation to apolipoprotein E polymorphism.
    Lehtovirta M, Partanen J, Könönen M, Hiltunen J, Helisalmi S, Hartikainen P, Riekkinen P, Soininen H.
    Dement Geriatr Cogn Disord; 2000 Sep; 11(1):29-35. PubMed ID: 10629359
    [Abstract] [Full Text] [Related]

  • 9. Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease.
    Monastero R, Mariani E, Camarda C, Ingegni T, Averna MR, Senin U, Camarda R, Mecocci P.
    Acta Psychiatr Scand; 2006 Jan; 113(1):59-63. PubMed ID: 16390371
    [Abstract] [Full Text] [Related]

  • 10. EEG functional connectivity and ApoE genotype in Alzheimer's disease and controls.
    Kramer G, van der Flier WM, de Langen C, Blankenstein MA, Scheltens P, Stam CJ.
    Clin Neurophysiol; 2008 Dec; 119(12):2727-32. PubMed ID: 18848805
    [Abstract] [Full Text] [Related]

  • 11. The effect of APOE epsilon4 allele on cerebral glucose metabolism in AD is a function of age at onset.
    Hirono N, Hashimoto M, Yasuda M, Ishii K, Sakamoto S, Kazui H, Mori E.
    Neurology; 2002 Mar 12; 58(5):743-50. PubMed ID: 11889238
    [Abstract] [Full Text] [Related]

  • 12. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
    Kleiman T, Zdanys K, Black B, Rightmer T, Grey M, Garman K, Macavoy M, Gelernter J, van Dyck C.
    Dement Geriatr Cogn Disord; 2006 Mar 12; 22(1):73-82. PubMed ID: 16699282
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R, Palmqvist S, Mattsson N, Andreasson U, Wallin A, Pålsson E, Jakobsson J, Herukka SK, Owenius R, Olsson B, Hampel H, Rujescu D, Ewers M, Landén M, Minthon L, Blennow K, Zetterberg H, Hansson O, Alzheimer’s Disease Neuroimaging Initiative.
    JAMA Psychiatry; 2014 Oct 12; 71(10):1183-91. PubMed ID: 25162367
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Apolipoprotein E epsilon4 allele frequency in vascular dementia.
    Davidson Y, Gibbons L, Purandare N, Byrne J, Hardicre J, Wren J, Payton A, Pendleton N, Horan M, Burns A, Mann DM.
    Dement Geriatr Cogn Disord; 2006 Oct 12; 22(1):15-9. PubMed ID: 16645276
    [Abstract] [Full Text] [Related]

  • 17. Association of CD33 rs3865444:C˃A polymorphism with a reduced risk of late-onset Alzheimer's disease in Slovaks is limited to subjects carrying the APOE ε4 allele.
    Javor J, Ďurmanová V, Párnická Z, Minárik G, Králová M, Pečeňák J, Vašečková B, Režnáková V, Šutovský S, Gmitterová K, Hromádka T, Peterajová Ľ, Shawkatová I.
    Int J Immunogenet; 2020 Oct 12; 47(5):397-405. PubMed ID: 32333488
    [Abstract] [Full Text] [Related]

  • 18. No effect of the alpha1-antichymotrypsin A allele in Alzheimer's disease.
    Didierjean O, Martinez M, Campion D, Hannequin D, Dubois B, Martin C, Puel M, Thomas Anterion C, Pasquier F, Moreau O, Babron MC, Penet C, Agid Y, Clerget-Darpoux F, Frebourg T, Brice A.
    J Neurol Neurosurg Psychiatry; 1997 Jul 12; 63(1):103-5. PubMed ID: 9221977
    [Abstract] [Full Text] [Related]

  • 19. Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele.
    Wishart HA, Saykin AJ, Rabin LA, Santulli RB, Flashman LA, Guerin SJ, Mamourian AC, Belloni DR, Rhodes CH, McAllister TW.
    Am J Psychiatry; 2006 Sep 12; 163(9):1603-10. PubMed ID: 16946187
    [Abstract] [Full Text] [Related]

  • 20. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T, Mirza N, Putnam KT, Linker G, Bhupali D, Durham R, Soares H, Kimmel L, Friedman D, Bergeson J, Csako G, Levy JA, Bartko JJ, Cohen RM.
    Biol Psychiatry; 2004 Nov 01; 56(9):670-6. PubMed ID: 15522251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.